So we know that non-compliance has enormous impacts on healthcare in both patient quality of life and unnecessary costs to an already overburdened healthcare system. There are direct and indirect ramifications of patient non-compliance that seep into various facets of everyday life – including the ability of patients, especially those affected by chronic diseases, to perform at their jobs. If you think about it, it makes sense – a person who isn’t compliant with their Diabetes treatment and lifestyle won’t be able to work in the same manner as someone who is. This affects both job performance as well as job attendance. In a 2009 study examining Employer Medication Compliance Initiatives, by The Benfield Group, they noted that “Medication compliance is among employers top health management objectives.” Though. currently, two thirds of the programs being implemented are ‘relatively’ unsophisticated providing only general educational information, as opposed to targeted and complex interventions and disease management programs for patients with specific conditions. Based on their findings, the most promising interventions are those that are personalized for individual employees at a higher risk of being non-compliant. “Initiatives that are characteristically more general in their approach are not perceived as being very effective.” Employers are currently concentrating on implementing value-based profit designs to improve compliance in the following areas; Diabetes, high cholesterol and blood pressure, cardiovascular disease, congestive heart failure, chronic obstructive pulmonary disease, asthma, depression and smoking cessation. Employers benefit from a healthier workforce with lower overall healthcare costs. Patients who adhere to their treatment cost significantly less. The costs savings to payors, health plans and employers are significant as increases in adherence reduce hospitalizations, critical care costs and productivity (absenteeism/presenteeism) and other indirect costs. With every increase in adherence, there is a reduction in overall healthcare costs despite an increase in drug expenses. Everyone stands to benefit from increased compliance, most of all…the patient and those who pay for their care.